Ms. Smiley has served as president and chief executive officer of VMS BioMarketing since 2011.
Ms. Smiley spent 18 years in the pharmaceutical industry leading multiple business units in the development and execution of biotech, device, and pharmaceutical product strategies to drive brand equity, increase market share, and improve patient adherence.
Ms. Smiley has served on the board of numerous organizations including the Indiana Alzheimer's Association, Indiana Salvation Army, and the Lung Force Women's Cabinet, and she received a gubernatorial appointment to the Indiana Commission for Women.
She earned her BA in economics from DePauw University where she was an Honors Management Fellow.
Ms. Hochberg has more than 30 years of leadership experience.
Currently she is a managing partner of Elaran LLC, a business strategy and management firm.
Previously, Ms. Hochberg worked for Forest Laboratories where, over 17 years, she rose through several positions to become the company's first chief commercial officer.
During her tenure, Ms. Hochberg helped transform Forest into a major mid-cap branded pharmaceutical company which lead to the company's acquisition by Actavis.
Prior to Forest, she was at Wyeth-Ayerst Laboratories and held product and marketing leadership roles in the pediatric and vaccines divisions. She serves on the board of Akcea Therapeutics and on several non-profit boards in New York City.
Ms. Hochberg earned her BA and MBA from Columbia University. ■
What to read next
LATEST MOVES FROM Pennsylvania
- Knoll CFO Craig Spray to resign
- Highmark Health appoints Cindy Donohoe as CMO
- StoneMor Partners appoints R. Paul Grady as CEO
- DICK'S Sporting Goods appoints Lauren Hobart as president
- Bon-Ton Stores chairman Tim Grumbacher to retire
More inside POST